T37.1X5
Adverse effect of antimycobacterial drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T37.1X5 pertains to adverse effects caused by antimycobacterial drugs. These medications are integral in treating tuberculosis and related infections but can sometimes lead to unwanted side effects. Recognizing these reactions early is crucial for managing patient care effectively.
Causes & Symptoms
Clinical Causes: Use of antimycobacterial drugs such as isoniazid, rifampicin, pyrazinamide, and ethambutol Prolonged treatment durations exposing patients to potential drug toxicity Individual genetic factors affecting drug metabolism leading to increased susceptibility Interactions with other medications that may enhance toxicity Pre-existing liver or kidney conditions increasing risk
Key Symptoms: Gastrointestinal discomfort like nausea, vomiting, or diarrhea Hepatotoxicity presenting as jaundice or elevated liver enzymes Neurological symptoms such as numbness, tingling, or weakness Visual disturbances, particularly with ethambutol Skin reactions, including rashes or hypersensitivity reactions General fatigue and malaise Signs of allergic reactions like swelling or difficulty breathing
Diagnostic & Treatment
Diagnosis Path: Diagnosing adverse effects involves a combination of clinical observation and laboratory tests. Healthcare providers may monitor liver function tests, renal function, and complete blood counts regularly during treatment. In cases of suspected drug toxicity, discontinuation or adjustment of medication may be necessary to confirm the adverse reaction.
Treatment Protocols: Discontinuing or substituting the offending antimycobacterial agent under medical supervision Providing symptomatic relief for side effects, such as anti-nausea medications or corticosteroids for hypersensitivity reactions Monitoring vital signs and laboratory parameters closely Supporting organ function, particularly liver and kidney health Adjusting the treatment regimen to balance efficacy and safety, potentially involving alternative therapies
Clinical Advice & FAQs
Billing Guidance
Is T37.1X5 a billable ICD-10 code?
Yes, T37.1X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T37.1X5?
Clinical documentation must specify the nature of Adverse effect of antimycobacterial drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference